|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.439
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.417
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.294
|
|
|
|
regulation of mast cell activation
|
GO:0033003 |
21 |
0.264
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.234
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.226
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.221
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.215
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.213
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.203
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.195
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.193
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.189
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.180
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.178
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.176
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.173
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.172
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.157
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.157
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.146
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.145
|
|
|
|
regulated secretory pathway
|
GO:0045055 |
32 |
0.144
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.138
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.137
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.136
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.136
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.130
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.130
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.128
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.126
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.124
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.122
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.120
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.120
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.120
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.117
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.115
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.115
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.115
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.114
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.114
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.111
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.110
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.109
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.105
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.105
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.103
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.098
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.097
|
|
|
|
regulation of regulated secretory pathway
|
GO:1903305 |
20 |
0.097
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.095
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.093
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.092
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.091
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.090
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.088
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.087
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.087
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.086
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.085
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.085
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.085
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.085
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.085
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.084
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.081
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.081
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.080
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.079
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.078
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.078
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.077
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.076
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.075
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.073
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.073
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.071
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.069
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.069
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.068
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.068
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.067
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.067
|
|
|
|
leukocyte degranulation
|
GO:0043299 |
27 |
0.067
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.067
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.066
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.065
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.064
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.064
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.064
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.063
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.063
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.062
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.061
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.059
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.058
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.056
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.056
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.056
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.056
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.055
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.054
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.053
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.052
|
|
|
|
epidermal growth factor receptor signaling pathway via i kappab kinase nf kappab cascade
|
GO:0038168 |
1 |
0.052
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.052
|
|
|
|
mast cell activation involved in immune response
|
GO:0002279 |
20 |
0.052
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.052
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.051
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.051
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.051
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.050
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.050
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.050
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.050
|
|
|
|
lysosome localization
|
GO:0032418 |
20 |
0.050
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.049
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.049
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.049
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.049
|
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.049
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.048
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.048
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.048
|
|
|
|
regulation of mast cell activation involved in immune response
|
GO:0033006 |
17 |
0.048
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.047
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.047
|
|
|
|
leukocyte cell cell adhesion
|
GO:0007159 |
14 |
0.047
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.046
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.046
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.045
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.045
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.045
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.045
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.045
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.044
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.044
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.043
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.043
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.043
|
|
|
|
regulation of leukocyte degranulation
|
GO:0043300 |
20 |
0.043
|
|
|
|
mast cell mediated immunity
|
GO:0002448 |
20 |
0.043
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.042
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.042
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.042
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.042
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.041
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.041
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.041
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.041
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.041
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.040
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.040
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.040
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.040
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.039
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.039
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.039
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.039
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.039
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.038
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.038
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.038
|
|
|
|
negative regulation of nik nf kappab signaling
|
GO:1901223 |
2 |
0.038
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.037
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.037
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.036
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.036
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.036
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.036
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.036
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.036
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.036
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.036
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.036
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.035
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.035
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.035
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.035
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.035
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.035
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.035
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.035
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.035
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.035
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.034
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.034
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.034
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.034
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.034
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.033
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.033
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.033
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.033
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.033
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.033
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.033
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.033
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.032
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.032
|
|
|
|
mast cell degranulation
|
GO:0043303 |
19 |
0.032
|
|
|
|
purinergic nucleotide receptor signaling pathway
|
GO:0035590 |
3 |
0.032
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.032
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.032
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.032
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.031
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.031
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.031
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.031
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.031
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.031
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.031
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.031
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.031
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.031
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.031
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.030
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.030
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.030
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.030
|
|
|
|
positive regulation of myeloid leukocyte mediated immunity
|
GO:0002888 |
14 |
0.030
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.029
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.029
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.029
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.029
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.029
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.029
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.029
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.029
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.028
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.028
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.028
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.028
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.028
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.028
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.028
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.028
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.028
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.028
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.028
|
|
|
|
regulation of protein tyrosine kinase activity
|
GO:0061097 |
17 |
0.028
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.028
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.028
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.028
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.028
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.028
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.027
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.027
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.027
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.027
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.027
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.027
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.027
|
|
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.027
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.027
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.027
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.026
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.026
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.026
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.026
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.026
|
|
|
|
production of molecular mediator involved in inflammatory response
|
GO:0002532 |
21 |
0.026
|
|
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.026
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.026
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.026
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.025
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.025
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.025
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.025
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.025
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.025
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.025
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.025
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.025
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.025
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.025
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.025
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.025
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.025
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.025
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.024
|
|
|
|
mast cell activation
|
GO:0045576 |
27 |
0.024
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.024
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.024
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.024
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.024
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.024
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.024
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.024
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.024
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.024
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.024
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.024
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.024
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.024
|
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.024
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.023
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.023
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
30 |
0.023
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.023
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.023
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.023
|
|
|
|
negative regulation of g protein coupled receptor protein signaling pathway
|
GO:0045744 |
12 |
0.023
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.023
|
|
|
|
positive regulation of mast cell activation involved in immune response
|
GO:0033008 |
10 |
0.023
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.023
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.023
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.023
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.023
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.023
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.023
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.023
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.023
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.023
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.023
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.022
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.022
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.022
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.022
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.022
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.022
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.022
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.022
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.022
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.022
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.022
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.022
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.022
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.021
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.021
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.021
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.021
|
|
|
|
regulation of toll like receptor 9 signaling pathway
|
GO:0034163 |
3 |
0.021
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.021
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.021
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.021
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.021
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.021
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.021
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.021
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.021
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.021
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.021
|
|
|
|
erythropoietin mediated signaling pathway
|
GO:0038162 |
1 |
0.021
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.020
|
|
|
|
smooth muscle cell chemotaxis
|
GO:0071670 |
2 |
0.020
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.020
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.020
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.020
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.020
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.020
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.020
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.020
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.020
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.020
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.020
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.020
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.020
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
20 |
0.020
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.020
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.019
|
|
|
|
negative regulation of muscle contraction
|
GO:0045932 |
12 |
0.019
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.019
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.019
|
|
|
|
regulation of serotonin secretion
|
GO:0014062 |
3 |
0.019
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.019
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.019
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.019
|
|
|
|
purinergic receptor signaling pathway
|
GO:0035587 |
7 |
0.019
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.019
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.019
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.019
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.019
|
|
|
|
regulation of metanephric mesenchymal cell migration
|
GO:2000589 |
2 |
0.019
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.019
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.018
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.018
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.018
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.018
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.018
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.018
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.018
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.018
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.018
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.018
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.018
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.018
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.018
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.018
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.018
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.018
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.018
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.018
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.018
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.018
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.018
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.018
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.018
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.018
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.018
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.017
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.017
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.017
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.017
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.017
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.017
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.017
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.017
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.017
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.017
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.017
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.017
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.017
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.017
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.017
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.017
|
|
|
|
positive regulation of exocytosis
|
GO:0045921 |
20 |
0.017
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.017
|
|
|
|
negative regulation of ras protein signal transduction
|
GO:0046580 |
18 |
0.017
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.017
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.016
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.016
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.016
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.016
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.016
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.016
|
|
|
|
positive regulation of metanephric mesenchymal cell migration
|
GO:2000591 |
1 |
0.016
|
|
|
|
arachidonic acid metabolite production involved in inflammatory response
|
GO:0002538 |
2 |
0.016
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.016
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.016
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.016
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.016
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.016
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.016
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.016
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.016
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.016
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.016
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.016
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.016
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.016
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.016
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.016
|
|
|
|
chemokine secretion
|
GO:0090195 |
5 |
0.016
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.016
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.016
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.016
|
|
|
|
phosphatidylinositol metabolic process
|
GO:0046488 |
45 |
0.016
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
29 |
0.016
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.015
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.015
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.015
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.015
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.015
|
|
|
|
cellular extravasation
|
GO:0045123 |
17 |
0.015
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.015
|
|
|
|
positive regulation of mast cell degranulation
|
GO:0043306 |
10 |
0.015
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.015
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.015
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.015
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.015
|
|
|
|
positive regulation of oocyte development
|
GO:0060282 |
4 |
0.015
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.015
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.015
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.015
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.015
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.015
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.015
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.015
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.015
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.015
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.015
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.015
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.015
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.015
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.015
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.015
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.015
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.014
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.014
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.014
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.014
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.014
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.014
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.014
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.014
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.014
|
|
|
|
mitochondrial transport
|
GO:0006839 |
36 |
0.014
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.014
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.014
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.014
|
|
